ACTINIUM PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -1.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-30
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -1.00%.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -2.00%.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -1.20%.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2017 was -0.50%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.00% 10-K · filed 2026-03-30 | |
| 2024-12-31 | -2.00% 10-K · filed 2026-03-30 | |
| 2023-12-31 | -1.20% 10-K · filed 2025-03-31 | |
| 2017-12-31 | -0.50% 10-K · filed 2019-03-15 | |
| 2016-12-31 | -3.90% 10-K · filed 2019-03-15 | -3.54% 10-K · filed 2017-03-16 |
| 2015-12-31 | -6.16% 10-K · filed 2016-03-11 | |
| 2014-12-31 | 3.04% 10-K · filed 2016-03-11 | |
| 2013-12-31 | 13.19% 10-K · filed 2016-03-11 | 19.29% 10-K · filed 2014-02-28 |
| 2012-12-31 | 23.56% 10-K · filed 2014-02-28 | 17.99% 10-K · filed 2013-03-29 |
| 2011-12-31 | 10.85% 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |